Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles

INTRODUCTION: Blood biomarkers represent a major advance for improving the management, diagnosis, and monitoring of Alzheimer's disease (AD). However, their context of use in relation to routine cerebrospinal fluid (CSF) analysis for the quantification of amyloid peptides and tau proteins remai...

Descripción completa

Detalles Bibliográficos
Autores principales: Delaby, Constance, Alcolea, Daniel, Hirtz, Christophe, Vialaret, Jérôme, Kindermans, Jana, Morichon, Lisa, Fortea, Juan, Belbin, Olivia, Gabelle, Audrey, Blennow, Kaj, Zetterberg, Henrik, Lleó, Alberto, Lehmann, Sylvain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Neurology and Preclinical Neurological Studies - Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866346/
https://www.ncbi.nlm.nih.gov/pubmed/35169889
http://dx.doi.org/10.1007/s00702-022-02474-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866346/
https://www.ncbi.nlm.nih.gov/pubmed/35169889
http://dx.doi.org/10.1007/s00702-022-02474-9

Ejemplares similares